Hyperparathyroidism
📧 Sign up to get email alerts when something new happens for Hyperparathyroidism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: Safety, Tolerability, and Clinical Effects of Twice-daily Doses of Cinacalcet (AMG 073) in Adults With Primary Hyperparathyroidism (HPT) [Phase 2]
Phase 2 trial update on twice-daily cinacalcet in adults with primary hyperparathyroidism evaluating safety, tolerability, and clinical effe…
-
CLINICAL_TRIALS trial_result · 2018-12-13Clinical Trial Update: Safety, Pharmacokinetics, and Clinical Effects of Cinacalcet (AMG 073) in Primary Hyperparathyroidism [Phase 2]
Phase 2 clinical trial evaluating safety, pharmacokinetics, and clinical effects of cinacalcet in primary hyperparathyroidism has completed.
-
FDA approval · 2018-10-11FDA Approved: CINACALCET — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved cinacalcet (Sun Pharmaceutical) via an original application; the generic CINACALCET is approved for secondary hyperparathyroidi…
-
FDA approval · 2018-10-09FDA Approved: PARICALCITOL — Original Application (Eugia US LLC)
FDA approved the original ANDA for paricalcitol from Eugia US LLC, a vitamin D receptor activator, for the treatment of secondary hyperparat…
-
FDA approval · 2018-08-20FDA Approved: PARSABIV — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for Parsabiv (etelcalcetide) from Amgen, updating the product labeling. The action relates to tr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-07-30Clinical Trial Update: Comparison of Cervical Ultrasound and Echoscintigraphy for Preoperative Localization Diagnosis in Primary Hyperparathyroidism [NA]
Clinical trial update comparing cervical ultrasound versus echoscintigraphy for preoperative localization in primary hyperparathyroidism.
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Phase 2 Study of KHK7580 [Phase 2]
Phase 2 study of KHK7580 for secondary hyperparathyroidism has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: EC17 for Intraoperative Imaging for Parathyroidectomy [Phase 1]
Completed Phase 1 study of EC17 for intraoperative imaging to assist parathyroidectomy in patients with primary hyperparathyroidism.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis [Phase 3]
Extension study of cinacalcet for secondary hyperparathyroidism in pediatric CKD patients on dialysis completed; results posted in 2018.
-
FDA approval · 2018-03-08FDA Approved: CINACALCET — Original Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s generic cinacalcet (cinacalcet) under an original ANDA for its approved indications: secondary hyperparathyroi…
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy [NA]
The clinical trial evaluating local analgesia as an adjunct to general anesthesia for thyroidectomy and parathyroidectomy has completed and …
-
CLINICAL_TRIALS trial_result · 2018-01-04Clinical Trial Update: Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas [Phase 2]
Phase 2 trial evaluating F18-choline as a second-line tracer for detecting parathyroid adenomas in hyperparathyroidism, completed.
-
CLINICAL_TRIALS trial_result · 2018-01-02Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism [Phase 1]
Phase 1 clinical trial updating safety, tolerability, and pharmacokinetics of etelcalcetide in hemodialysis patients with secondary hyperpar…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis [Phase 3]
An extension study of etelcalcetide for secondary hyperparathyroidism in patients with chronic kidney disease on hemodialysis has completed,…
-
CLINICAL_TRIALS research · 2017-10-27Clinical Trial Update: Corticosteroid Rhythms in Hypoparathyroid Patients [EARLY_Phase 1]
An early Phase 1 clinical trial sponsored by the University of Bergen investigates corticosteroid rhythms in patients with hypoparathyroidis…
-
CLINICAL_TRIALS research · 2017-10-26Clinical Trial Update: The Effect of Diuretics on Mineral and Bone Disorder in Chronic Kidney Disease Patients [NA]
A clinical trial is investigating the effects of diuretics on mineral and bone disorders in chronic kidney disease patients. The study inclu…
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis [Phase 3]
Phase 3 trial assessing efficacy and safety of cinacalcet in pediatric patients with secondary hyperparathyroidism on dialysis; study termin…
-
CLINICAL_TRIALS withdrawal · 2017-08-25Clinical Trial Update: Surgical Approach for Primary Hyperparathyroidism in the Elderly [NA]
The clinical trial NCT01484379 investigating surgical approaches for primary hyperparathyroidism in elderly patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis [Phase 2]
Deltanoid's oral vitamin D compound DP001 completed a Phase 2 study evaluating its effects in secondary hyperparathyroidism among patients o…
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism [Phase 2]
A completed Phase 2A dose-ranging study evaluated the pharmacokinetics and dosing of the oral vitamin D compound DP001 in secondary hyperpar…
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism [Phase 2]
Phase 2 trial evaluating safety and tolerability of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyr…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study [NA]
A completed clinical trial investigating the RAAS-PARC study related to hyperparathyroidism; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: Effect of Parathyroidectomy on Sleep [NA]
This clinical trial update reports on the completed study examining how removing the parathyroid glands (parathyroidectomy) affects sleep in…
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: Phase 3 Study of KHK7580 [Phase 3]
A Phase 3 study of Kyowa Kirin's KHK7580 for secondary hyperparathyroidism has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: Phase 3 Study of KHK7580 [Phase 3]
A Phase 3 study of Kyowa Kirin's KHK7580 for secondary hyperparathyroidism has completed its Phase 3 trial.